Procept BioRobotics is a surgical robotics company based in San Jose, California that is dedicated to improving patient care by developing innovative solutions in the field of urology. The company has recently announced that members of management will be presenting at the 44th Annual TD Cowen Health Care Conference in Boston. The presentation is scheduled for Tuesday, March 5 at 12:50 p.m. Eastern Time and can be accessed through a live webcast as well as an archived recording on the “Investors” section of their website.
The focus of Procept BioRobotics is on developing, manufacturing, and selling the AquaBeam Robotic System, an advanced image-guided surgical robotic system designed for minimally invasive urologic surgery. The initial use case for this system is treating benign prostatic hyperplasia (BPH), a common prostate disease affecting approximately 40 million men in the United States. Procept BioRobotics aims to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms (LUTS) due to BPH, regardless of prostate size and shape or the surgeon’s experience. The company has developed a substantial body of clinical evidence, including nine clinical studies and over 150 peer-reviewed publications, to support the benefits and clinical advantages of Aquablation therapy.
If you’re interested in learning more about this innovative system and the company’s advancements in urology, you can access a live webcast and an archived recording of the presentation for at least 90 days after the event on the “Investors” section of their website.